Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Electron transfer flavoprotein subunit alpha is one subunit of the heterodimeric electron transfer flavoprotein (ETF) complex, a mitochondrial matrix enzyme that functions as a central electron acceptor for multiple flavoprotein dehydrogenases involved in fatty acid and amino acid metabolism[1][2][3][4][5]. The ETF complex consists of an alpha subunit (ETFA) and a beta subunit (ETFB), together binding the cofactor flavin adenine dinucleotide (FAD)[4][5][6]. ETF collects electrons from at least 14 mitochondrial dehydrogenases and relays these electrons to the respiratory chain via electron transfer flavoprotein-ubiquinone oxidoreductase, contributing to cellular ATP production[5]. Mutations in the ETFA gene can cause multiple acyl-CoA dehydrogenase deficiency (glutaric acidemia type II), a severe inherited disorder of metabolism that affects the breakdown of fatty acids and amino acids[6]. This subunit does *not* function as a classical therapeutic target such as a receptor or transporter, but is an important enzyme for mitochondrial metabolism and energy production[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Electron transfer flavoprotein subunit alpha (ETFA).